-
University of San Agustin in Iloilo earns patent for kadios antibiotic
16 Dec 2025 03:47 GMT
ILOILO CITY — The University of San Agustin (USA) has earned a patent for creating an antibiotic from the seeds of kadios, an ingredient of a beloved Ilonggo dish known as "KBL."
The Intellectual Property Office of the Philippines (IPOPHL) …
-
OP6 CBD: Redefining Athletic Recovery Without Pharmaceuticals
16 Dec 2025 04:37 GMT
For our latest Q&A interview, we connected with the people behind OP6 CBD, a wellness-focused CBD topicals manufacturer whose high-potency products are geared toward athletic recovery and everyday mobility. Craig Zaffe, a longtime independent medical …
-
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
16 Dec 2025 01:29 GMT
… that bridges the gap between pharmacy cold-chain requirements and real … TempraMed’s reach across retail pharmacy chains, HMOs, and healthcare networks … life-saving medications, TempraMed develops patented, FDA-registered, space-grade thermal …
-
Agreement Reached on EU Pharma Package, but Questions Remain
16 Dec 2025 00:56 GMT
Two and a half years after the initial proposal, agreement has been reached by the EU institutions on the so-called EU Pharma Package. The Package represents a comprehensive overhaul of the European Union’s pharmaceutical framework for medicinal products, …
-
Shenzhen Targetrx patents new Bcr-Abl1 degradation inducers
15 Dec 2025 20:30 GMT
Cancer
Shenzhen Targetrx Inc. has disclosed proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to a Bcr-Abl (Bcr-Abl1) kinase and its mutant targeting moiety through a linker reported to be …
-
New KIF18A inhibitors disclosed in Inventisbio patent
15 Dec 2025 20:30 GMT
-
EU Pharmaceutical Legislation to be Reformed After 2 Decades
15 Dec 2025 18:45 GMT
… comprehensive overhaul of the EU pharmaceutical legislation, the first major … market exclusivity.
This EU pharmaceutical legislation restructuring aims to maintain … submissions on a patented medicine without facing patent-infringement claims, provided …
-
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
15 Dec 2025 17:01 GMT
… is PharmAla';s patented, novel, non-racemic MDMA formulation. PharmAla has … in clinical research. About PharmAla Pharmala Biotech Holdings Inc. (CSE: … Risk Factors" in PharmAla';s management's … is available on PharmAla';s profile at www. …
-
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
15 Dec 2025 17:01 GMT
NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026 NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that …
-
U.S. Court of Appeals Affirms Novarad’s ’807 Patent as Company Continues to Defend Leadership in Augmented Reality Surgical Navigation
15 Dec 2025 16:00 GMT
Salt Lake City, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Novarad Corporation, a global leader in medical imaging and immersive augmented reality surgical navigation, today announced that the United States Court of Appeals for the Federal Circuit, one level …
About
© 1995-2025